Peter Kaiser

CIK: 0002011869

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OCUL

OCULAR THERAPEUTIX, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2026
Sale(S)
Direct
10K shares at avg. $7.05$70K
OCUL
OCULAR THERAPEUTIX, INC
Aug 24, 2026
Sale(S)
Direct
3K shares at avg. $10.77$33K
OCUL
OCULAR THERAPEUTIX, INC
May 26, 2026
Sale(S)
Direct
3K shares at avg. $8.20$24K
OCUL
OCULAR THERAPEUTIX, INC
Feb 23, 2026
Sale(S)
Direct
2.8K shares at avg. $8.28$23K
OCUL
OCULAR THERAPEUTIX, INC
Jan 2, 2026
Award(A)
Direct
79.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 24, 2025
Sale(S)
Direct
3K shares at avg. $12.02$36K
OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2025
Sale(S)
Direct
9.7K shares at avg. $11.03$106K
OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2025
Sale(S)
Direct
3K shares at avg. $12.04$36K
OCUL
OCULAR THERAPEUTIX, INC
May 23, 2025
Sale(S)
Direct
3K shares at avg. $7.17$21K
OCUL
OCULAR THERAPEUTIX, INC
Feb 24, 2025
Sale(S)
Direct
3K shares at avg. $6.87$21K
OCUL
OCULAR THERAPEUTIX, INC
Nov 25, 2024
Sale(S)
Direct
2.9K shares at avg. $9.01$26K
OCUL
OCULAR THERAPEUTIX, INC
Oct 2, 2024
Award(A)
Direct
100K shares-

		Type	Shares	Price		Ownership
Oct 2, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	9,990	$7.05	$70,430	Direct
Aug 24, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,035	$10.77	$32,687	Direct
May 26, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	2,967	$8.20	$24,329	Direct
Feb 23, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	2,810	$8.28	$23,267	Direct
Jan 2, 2026	OCUL OCULAR THERAPEUTIX, INC	Award(A)	79,112	-	$0	Direct
Nov 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,007	$12.02	$36,144	Direct
Oct 2, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	9,653	$11.03	$106,473	Direct
Aug 25, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,011	$12.04	$36,252	Direct
May 23, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	2,974	$7.17	$21,324	Direct
Feb 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	3,009	$6.87	$20,672	Direct
Nov 25, 2024	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	2,897	$9.01	$26,102	Direct
Oct 2, 2024	OCUL OCULAR THERAPEUTIX, INC	Award(A)	100,000	-	$0	Direct

1-12 of 12 transactions

About Kaiser Peter

Kaiser Peter (SEC CIK 0002011869) files insider reports with the SEC as Chief Development Officer of OCULAR THERAPEUTIX, INC (OCUL).

Signal8 holds 13 ownership filings by Kaiser Peter (1 Form 3, 12 Form 4), filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 12 transactions, from Oct 2, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kaiser Peter's filings is in BEDFORD, MA.

Recent filings by Kaiser Peter

Oct 2, 2026: Open-market sale of OCUL shares (Form 4, code S).
Aug 24, 2026: Open-market sale of OCUL shares (Form 4, code S).
May 26, 2026: Open-market sale of OCUL shares (Form 4, code S).
Feb 23, 2026: Open-market sale of OCUL shares (Form 4, code S).
Jan 2, 2026: Grant or award of OCUL shares (Form 4, code A).

Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)

Anderman Todd, Chief Legal Officer
Heier Jeffrey S., Chief Scientific Officer
Notman Donald, Chief Operating Officer
Nayak Sanjay, Chief Strategy Officer
Dugel Pravin
Warden Charles M, Director

How to read Form 4 transaction codes